News Roche to file Actemra in inflamed artery disease Drug successful in late stage trial for giant cell arteritis
News Embattled Mylan files Herceptin biosimilar in US But senators call for investigation into EpiPen schools contracts.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
News Three's a crowd as Tecentriq approved in lung cancer Cancer immunotherapy approved in second line.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.